New Monoterpenoid Indole Hybrids from Gelsemium elegans with Anti‐Inflammatory and Osteoclast Inhibitory Activities
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202301665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Pan-Pan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, People's Republic of China. Hauptthemen laut MEDLINE: Osteoclasts, Gelsemium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Province Basic Research Program, Natural Science Research Program of Guizhou Provincial Department of Education.
Abstract (Originalsprache)
Gelsegansymines A ( 1 ) and B ( 2 ), two new indole alkaloids along with six known analogues ( 3 – 8 ) were isolated from the aerial parts of Gelsemium elegans . Their structures were elucidated by means of spectroscopic techniques. Structurally, compounds 1 and 2 possessed the rare cage‐like gelsedine skeleton hybrid with bicyclic monoterpenoid. The anti‐inflammatory activities of isolated compounds ( 1 – 3 ) were tested on LPS induced RAW264.7 cells. Under the treated concentration without toxicity for cells, the cytokines levels of nitric oxide (NO), tumor necrosis factor‐ α (TNF‐ α ) and interleukin‐6 (IL‐6) were evaluated by Griess method and enzyme‐linked immunosorbent assay (ELISA). The results showed that compounds 1 – 3 exhibited anti‐inflammatory activities with dose‐dependent manner range from 12.5 to 50 μmol/L. Furthermore, the inhibitory activities of compounds 1 and 2 on receptor activator of NF‐κB ligand (RANKL) induced osteoclast formation were tested in vitro . Compounds 1 and 2 at 5 μ mol/L exhibited the significant inhibitory effect on the osteoclastogenesis induced by RANKL. This work reported the anti‐inflammatory and osteoclast inhibitory activities of new monoterpenoid indole hybrids, which may inspire the further light on the related traditional application research of G. elegans .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, People's Republic of China.
- Natural Products Research Center of Guizhou Province, Guiyang, 550014, People's Republic of China.
- Yunnan Academy of Scientific & Technical Information, Kunming, 650500.
Förderung
- National Natural Science Foundation of China
- Guizhou Province Basic Research Program
- Natural Science Research Program of Guizhou Provincial Department of Education
- Major Science and Technology Project of Yunnan Province
Zitieren
APA
Zhang, P. P., Liang, J. J., Lu, Q. Y., Yin, X., Zhou, Y. Q., Feng, T. T., Zhou, Y., Chang, D., & Wei, X. (2023). New Monoterpenoid Indole Hybrids from Gelsemium elegans with Anti‐Inflammatory and Osteoclast Inhibitory Activities. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301665
Vancouver
Zhang PP, Liang JJ, Lu QY, Yin X, Zhou YQ, Feng TT, et al. New Monoterpenoid Indole Hybrids from Gelsemium elegans with Anti‐Inflammatory and Osteoclast Inhibitory Activities. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202301665
BibTeX
@article{Zhang2023,
author = {Zhang, Pan-Pan and Liang, Jia-Jun and Lu, Qing-Yu and Yin, Xin and Zhou, Yong-Qiang and Feng, Ting-Ting and Zhou, Ying and Chang, Dong and Wei, Xin},
title = {New Monoterpenoid Indole Hybrids from Gelsemium elegans with Anti‐Inflammatory and Osteoclast Inhibitory Activities},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202301665}
}
EUVIMED